Dr Sunil Ajagar is a visionary leader in the pharmaceutical industry with over 25 years of expertise spanning quality control and analytical research & development laboratories

sunil

Dr Sunil Ajagar is a visionary leader in the pharmaceutical industry with over 25 years of expertise spanning quality control and analytical research & development laboratories. Currently serving as General Manager – Quality Control at Swiss Garnier Genexiaa Sciences, he drives excellence in delivering high-quality pharmaceutical solutions across tablets, capsules, injectables, liquids, creams and powders, ensuring that science, compliance, and innovation come together to create products that make a meaningful impact on patients and healthcare systems.

Throughout his illustrious career, Dr. Ajagar has contributed to Misom Labs Ltd., Agios Pharmaceuticals, Emcure Pharmaceuticals Limited, Micro Labs Limited, Troikaa Pharmaceuticals Ltd., Torrent Pharma Inc., Merck Development Centre, SUN PHARMA, Gharda Chemicals, and Hikal Ltd., successfully leading both QC and Analytical Development Laboratories and executing projects across global markets including US, EU, ROW and domestic regulatory environments. His expertise encompasses method validation, technology transfer, stability studies, polymorphism analysis and characterization of known and unknown impurities.

Known for his strategic mindset, technical mastery, and disciplined execution, he has implemented robust quality systems, steered successful GLP and GMP audits and prepared regulatory submissions such as DMFs and ANDAs. His work in complex formulations, including injectables, tablets, capsules and creams, has earned him a reputation as a trusted authority in pharmaceutical quality management.

Beyond his technical achievements, Dr. Ajagar is reshaping the future of QC and analytical development by fostering innovation, mentoring high-performing teams and enhancing operational efficiency, ensuring organizations not only meet compliance standards but also achieve sustainable growth and excellence. His global experience and forward-thinking approach make him a transformative leader in the pharmaceutical sector.